Microfluidic apparatus, microfluidic system, and method for capturing and controllably releasing a single living cell
The microfluidic device facilitates single-cell capture and controllable release, addressing the limitations of existing methods by enabling dynamic analysis and correlation of metabolic and genetic data for disease understanding.
Patent Information
- Application Number
- JP2026519350
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2023-09-28
- Filing Date
- 2024-09-27
- Publication Date
- 2026-11-19
AI Technical Summary
Current methods for single-cell analysis, such as microscopy, transcriptomics, and proteomics, provide only snapshots of cellular processes and do not capture dynamic functional processes, and there are no techniques to correlate single-cell metabolism with transcriptomic and epigenetic evaluations.
A microfluidic device with a conductive capture surface functionalized by immobilizers for binding cells, allowing controllable release using electrochemically detachable adhesion, integrated with semiconductor manufacturing techniques for precise cell capture and analysis.
Enables the analysis and understanding of cellular heterogeneity by capturing and releasing single cells for further evaluation, correlating metabolic properties with transcriptomic and epigenetic data for disease treatment guidance.
Smart Images

Figure 2026538957000001_ABST
Abstract
Description
Technical Field
[0001] The present disclosure relates to a microfluidic device for trapping a single biological cell and controllably releasing a selected single biological cell. The present disclosure further relates to a microfluidic system comprising at least one such microfluidic device, and to a method for trapping a single biological cell and releasing a selected single biological cell in a microfluidic system.
Background Art
[0002] Cells are the fundamental building blocks of life. To perform their functions, both prokaryotic and eukaryotic cells are extremely heterogeneous in terms of gene expression. Differences in gene expression are critical in how cells respond not only to drugs but also to environmental stimuli, for example in how efficiently immune cells can clear an infection, or whether bacteria can be killed by antibiotics.
[0003] The advent of single-cell techniques such as microscopy, transcriptomics, epigenetics, and proteomics has enabled investigations into cellular heterogeneity at unprecedented levels. However, common to these single-cell methods is that they only provide snapshots of cellular processes and do not include insights into the dynamic functional processes occurring in individual cells. Accordingly, what induces the observed cellular heterogeneity remains a largely unresolved biological problem.
[0004] Recent observations suggest that metabolic changes in immune cells are associated with most pathologies, including cancer, autoimmunity, and inflammation. Similarly, the metabolism of individual microbial cells also varies within a cell population, which can explain why bacterial and fungal subpopulations continue to self-replicate when exposed to certain antibiotics and antifungal agents.
[0005] However, the current gold standard method for outlining cellular metabolism is limited to the analysis of at least 10,000 cells. Outlining single-cell metabolism to examine the dynamic functional processes of a single cell has not yet been achieved. Therefore, how metabolism contributes to cellular heterogeneity remains uncharacterized.
[0006] Furthermore, there are currently no techniques that allow for the correlation between the metabolism of a single cell or a population of more cells and the transcriptomic and epigenetic evaluation of a single cell or a population of more cells. This correlation is crucial for understanding how metabolic heterogeneity arises and what kind of gene expression profiles this heterogeneity results in. [Overview of the Initiative] [Problems that the invention aims to solve]
[0007] Therefore, the object of this disclosure is to provide a device for capturing a single living cell for single-cell analysis and for controllably releasing a selected living cell for further evaluation. More specifically, the object of this disclosure is to provide a microfluidic device, system, and method for capturing a single living cell for single-cell analysis and for controllably releasing a selected single living cell. [Means for solving the problem]
[0008] In accordance with a first aspect of this disclosure, the object is at least partially achieved by the microfluidic device according to claim 1.
[0009] Therefore, a microfluidic device is provided for capturing and controllingly releasing living cells. The microfluidic device comprises at least one microchamber having a first fluid opening and a second fluid opening for flowing a liquid sample through the microchamber. The microfluidic device further comprises at least one capture device inside the microchamber for capturing at least one living cell inside the microchamber.
[0010] The capture device comprises a conductive capture surface that can be electrically connected to an external potential. The capture surface is further functionalized by at least one immobilizer selected to bind to at least one living cell in a microchamber. The at least one immobilizer is bonded to the capture surface using electrochemically detachable adhesion configured to detach from the capture surface when a potential greater than a threshold potential is applied to the capture surface.
[0011] Regarding the reference potential, the absolute value of the applied potential is greater than the absolute value of the threshold potential. The reference potential can be the reference potential of the liquid in the microchamber.
[0012] Microfluidic devices may be manufactured at low cost by conventional semiconductor manufacturing techniques combined with other techniques such as additive manufacturing and 3D printing. Therefore, microfluidic devices may be mounted on glass or semiconductor substrates or chips. The capture device, comprising a capture surface and either electrode, may be manufactured by conventional semiconductor techniques, integrated into the microfluidic device by deposition, or patterned by conventional means known in the art.
[0013] Microfluidic structures such as the chamber walls, fluid channels, and openings of a microchamber may be formed from a single material on a substrate by additive manufacturing on a semiconductor wafer or chip prefabricated by semiconductor technology to include components such as a trapping device. Any microfluidic structures of this disclosure, such as the walls and top cover of a microchamber, as well as any connecting channels and openings, such as inlets and outlets, may be fabricated by conventional techniques using polydimethylsiloxane (PDMS) or glass on a prepared semiconductor or glass substrate.
[0014] A fluid opening is positioned to introduce or remove a fluid into the microchamber. The fluid may be a cell-containing liquid sample, i.e., a liquid sample containing living cells, or a fluid containing a culture medium for growing living cells. The fluid containing the culture medium may or may not contain other components for performing tests on living cells. The fluid may also be used to remove living cells from the microchamber.
[0015] Functionalization of the capture surface should be understood as the capture surface being biologically / chemically prepared with selected components, or "immobilizers," configured to bind to living cells. The immobilizers are further bonded to the capture surface by electrochemically detachable adhesions, allowing them to be released from the capture surface when an external voltage of a predetermined magnitude is applied.
[0016] In this specification, "binding" to living cells within a microchamber should be understood as preventing the living cells from detaching from the microchamber through biochemical binding between the cells and the immobilizer on the functionalized capture surface.
[0017] This specification discloses capture, controllable release, and optional testing of a single living cell. If a predetermined property of a living cell is detected by monitoring the cell in a microchamber, the cell may be selected for further investigation, released from the microchamber, and evacuated / removed. The released cell(s) may be carried out for further analysis along with any other cells identified by their properties in a microfluidic system comprising multiple such microfluidic devices. As a result, this disclosure enables the analysis and better understanding of cellular heterogeneity in cell populations, for example, with respect to metabolism and gene expression. In other words, living cells may be monitored, and optionally, after exposing a sample of cells to a test component such as a predetermined antibiotic, one or more cells exhibiting various properties, such as resistance to the antibiotic, may be selected for further analysis. Monitored properties of a single cell, such as metabolism, may be correlated with transcriptomic and epigenetic evaluations of the same single cell, and this correlation may contribute to an understanding of how properties such as metabolism contribute to cellular heterogeneity, which may provide important guidance for the treatment of diseases.
[0018] In this specification, monitoring should be understood to refer to any of the following: optical investigation of the properties of living cells, electrical measurement of the properties of living cells, or a combination of both optical investigation and electrical measurement of the properties of living cells.
[0019] Optionally, the detachable bond is configured to a threshold potential having an absolute value in the range of 0.1V to 25V, or more preferably, in the range of 0.1V to 5V. Different immobilizer choices may result in different electrochemical bond strengths, and it may be necessary to apply external potentials of varying magnitudes to detach the bond.
[0020] Optionally, the capture device is configured to capture a single living cell within the microchamber. The capture device may be sized, for example, to accommodate only a single cell. This ensures that any further cells within the microchamber are not bound by the capture device and are removed from the microchamber before monitoring begins.
[0021] The first and second fluid openings may be located on either side of the capture device in the lateral direction. This allows the capture device to be positioned within the flow of the liquid sample.
[0022] Optionally, the capture device may include a cell stopper positioned adjacent to the capture surface and protruding perpendicularly to the capture surface. This allows the cell to be mechanically slowed or even stopped, increasing the opportunity to capture a single cell and form a biochemical junction between the cell and the capture surface.
[0023] Optionally, the cell stopper is configured to be wider and taller than the maximum cellular range of the living cells intended to be captured using the microfluidic device. The width and height are the protruding range of the cell stopper, perpendicular to the direction of fluid flow through the operating microchamber. A sufficiently large cell stopper increases the chances of holding and slowing a single living cell.
[0024] For reference, various types of living cells vary in size from several hundred nanometers to several tens of micrometers. The disclosed microfluidic devices and systems can be manufactured and housed by laboratories in various sizes intended for a wide range of living cell diameters. Therefore, when a given living cell type is under test, the size of the living cell type may be determined, and a correspondingly sized test system having a microchamber sized for an appropriate range of living cell sizes may be selected from the housed test systems. In particular, the maximum and / or minimum cell range for a given living cell type is determined.
[0025] As an alternative, if the biological cell type is unknown, a test system comprising differently sized microchambers, where different microchambers are dimensioned for different predetermined ranges of cell sizes, may be selected. As a result, time is saved because the biological cells do not need to be investigated before the test begins.
[0026] A predetermined range of cell sizes is to be understood herein as a range of cell sizes that enables separation / detection of biological cells of a limited range of sizes, that is, cells that are similarly sized but not necessarily identically sized. Thereby, a specific microchamber will be designed to accommodate cells of a limited range of sizes for testing. Other microfluidic devices may be simultaneously designed and used for other predetermined ranges of biological cell sizes, thereby enabling blind testing for cells of unknown type and size. This is because in the microfluidic system of microchambers, some of the microchambers will be correctly dimensioned for the unknown cell type.
[0027] Optionally, the cell stop is configured such that its width and / or height is less than three times the maximum cell range of the biological cells intended to be captured using the microfluidic device. By making the cell stop even larger, the chance of capturing cells can be increased.
[0028] Optionally, the cell stop comprises a concave surface that faces the first fluid opening when viewed from the first fluid opening, is adjacent to the capture surface, and is disposed on the opposite side of the capture surface. Accordingly, biological cells packed into the microchamber can flow over the capture surface and be stopped or decelerated by the cell stop on the opposite side of the capture surface. The concave surface can increase the chance of retaining the cell by the cell stop until a biochemical junction between the biological cell and the immobilizer is formed.
[0029] Optionally, the cell stop comprises a microchannel arranged to extend through the cell stop, the microchannel having a concave first aperture and a second aperture on another surface of the cell stop, wherein the second aperture is closer to the second fluid opening compared to the first aperture. A portion of the flowing fluid (liquid sample) can flow into the cavity formed by the concave surface and pass through the microchannel toward the second fluid opening, such that the fluid flow assists in drawing cells into the cavity formed by the concave surface, thereby improving the trapping characteristics of the cell stop.
[0030] Optionally, the conductive capture surface comprises a metal, or a metal alloy containing at least 50% of a metal such as silver (Ag) or gold (Au). Silver and gold are excellent conductors and are well suited for forming chemical bonds with the immobilizer.
[0031] Optionally, the electrochemically dissociable adhesion between the capture surface and the at least one immobilizer is a thiol bond, a sulfide bridge, or a sulfur bridge.
[0032] Optionally, the immobilizer comprises a linker molecule.
[0033] Optionally, the linker molecule is -S-(CH2)x-.
[0034] Optionally, the capture device comprises a passivation layer on at least a portion of the capture surface, the passivation layer being configured to prevent undesired bonds from forming on the capture surface. The passivation layer can prevent contamination of the capture surface, such as preventing unwanted molecules from adhering to the capture surface. Contamination can adversely affect the monitoring of the microchamber.
[0035] Optionally, the passivation layer comprises thiolated mercaptohexanol (MCH).
[0036] Optionally, the immobilizer includes a cell binder selected from nucleotides, amino acids, and / or oligosaccharides.
[0037] Optionally, the immobilizer includes a cell binder selected from DNA, RNA, XNA, and / or antibodies.
[0038] Optionally, the immobilizer includes a cell binder selected from aptamers and / or antibodies.
[0039] Optionally, the immobilizer includes ligands for affinity binding to living cells.
[0040] Optionally, the microchamber can be configured to monitor the characteristics of captured living cells.
[0041] Optionally, the microchamber is configured for optical monitoring of captured living cells, and the monitored properties indicate the movement and / or morphology of the captured living cells.
[0042] The microchamber may be arranged with an optically transparent cover. In this way, the captured cells may be optically monitored by a microscope or by an external light sensor.
[0043] Optionally, the microchamber is configured for electrical monitoring of captured living cells, and the monitored characteristics indicate the metabolism, lysis, pyroptosis, and / or apoptosis of the captured living cells.
[0044] Electrical monitoring may be performed by monitoring the electrically detected characteristics of the cell-containing solution within the microchamber.
[0045] Optionally, the microchamber may be equipped with an integrated sensor, which is configured to monitor the characteristics of captured living cells. The sensor may be an integrated semiconductor electronic sensor for real-time monitoring of the cell's activity state. "Integrated" means that the sensor can be manufactured on a glass or semiconductor substrate using conventional semiconductor processing techniques.
[0046] Optionally, the integrated sensor is an ion-sensitive field-effect transistor (ISFET), such as a potentiometric ion sensor. In microfluidic devices, small-sized and highly sensitive integrated semiconductor sensors can facilitate the direct monitoring of single cells. Ion-sensitive field-effect transistors can be configured to monitor the metabolism of living cells by monitoring pH changes induced by the metabolism of the culture medium.
[0047] From a detection standpoint, measuring the potential difference of pH using a field-effect transistor is more reliable than directly monitoring the resistance (or impedance) of the culture medium. This is because contributions from the solid-liquid interface between the electrode and the liquid can introduce large and irregular errors into resistance measurements.
[0048] Furthermore, direct monitoring of physiological parameters (such as the pH of the culture medium) can potentially be faster than optical monitoring of cell growth because it does not rely on visible morphological changes synchronized with signal generation. Monitoring of physiological parameters can potentially provide a real-time overview of the drug response of living cells using highly sensitive and reliable field-effect transistor-based ion sensors. The effect of a drug can be immediately detected from changes in electrical signals generated by monitored characteristics such as cellular metabolism. The tests are all electrical and can be obtained based on current-voltage measurements using conventional instruments.
[0049] Before monitoring is performed on the cell-containing sample within the microchamber, the first fluid opening and / or the second fluid opening may be closed with a sealing fluid such as oil to isolate the microchamber.
[0050] Optionally, the microchamber includes a first electrode configured to define a reference potential for the liquid sample within the microchamber. If the microchamber includes an integrated sensor, the first electrode can define a reference potential for the integrated sensor.
[0051] Optionally, the first electrode is made of a material selected from silver chloride (AgCl) or silver (Ag) to a minimum of 50%.
[0052] Optionally, the microchamber may be equipped with a second electrode.
[0053] Optionally, the second electrode is made of at least 50% platinum (Pt).
[0054] Optionally, the first and second electrodes form an oxygen redox cell for measuring the oxygen content and / or oxygen concentration within the microchamber 10. Thus, the microchamber further equipped with sensors may be configured to monitor one or a combination of oxygen content, oxygen concentration, and acidification / metabolism.
[0055] Optionally, the microfluidic device comprises a substrate extending laterally in a plane, and a microchamber and a capture device are arranged on the substrate. The substrate may extend laterally in a plane including a second axis and a third axis perpendicular to the second axis. The plane is perpendicular to the first axis.
[0056] According to a second aspect of this disclosure, the objective is at least partially achieved by the microfluidic system according to claim 31.
[0057] Accordingly, a microfluidic system is provided comprising a plurality of microfluidic devices according to any one embodiment of the first aspect of the present disclosure, each microchamber being fluidly connected to a first fluid channel via a first fluid opening and to a second fluid channel via a second fluid opening.
[0058] The microfluidic system may comprise at least one array of microfluidic devices interconnected by a first fluid channel and a second fluid channel. Each array of microfluidic devices may be interconnected by its respective first fluid channel and second fluid channel. Each array of microfluidic devices may be supplied with a liquid cell-containing sample during testing. The first and second fluid openings of the microfluidic devices included in the microfluidic system may be closed by filling the first and second fluid channels with a sealing fluid such as oil. Alternatively, the first and second fluid openings may be closed by shut-off valves to which the first and second fluid channels are connected.
[0059] Optionally, the microfluidic system may further include an integrated electrical interconnect configured to electrically connect any electrodes and sensors within the microfluidic system to an external electrical unit for monitoring an external voltage potential and selectively applying the external voltage potential to the capture surface of the capture device, in order to selectively disengage the immobilizer from the capture surface of the capture device. The external electrical unit may be exemplified by a control unit, a voltage source, a measurement unit, and the like.
[0060] Optionally, the microfluidic system further comprises a control unit for controlling the operation of at least one microfluidic device. The control unit may be electrically connected to the capture surface of at least one microchamber and may be configured to selectively apply an external voltage potential to the capture surface of the capture device in order to selectively disengage the immobilizer from the capture surface.
[0061] The control unit may be electrically connected to the microfluidic system to receive signals from each of the sensors in the microchambers included in the system via an integrated electrical interconnect. The control unit can interpret the sensor readings and provide a rapid presentation of the state of the living cells in the microchambers.
[0062] In accordance with a third aspect of this disclosure, the objective is at least partially achieved by the method according to claim 33.
[0063] Therefore, a method is provided for testing living cells using a microfluidic system according to any one of the embodiments of the second aspect of this disclosure. The method is: The steps include: packing at least one living cell into at least one microfluidic device by flowing a cell-containing liquid sample through a microchamber in a first direction; The steps include capturing living cells using a capture device, A step to monitor the characteristics of captured living cells, Based on the monitored characteristics, a step of selecting captured living cells for release, The steps include applying an external potential greater than the threshold potential to the capture surface of a capture device, thereby capturing selected living cells within the capture device, thereby dissociating their chemical bonds, and thereby releasing the selected living cells. The procedure includes the step of removing the released biological cells from the microfluidic device by flowing a fluid through the microchamber in a first direction or a second direction opposite to the first direction.
[0064] Thus, a cell-containing liquid sample is prepared and can be fluidly connected to at least one microfluidic device in a microfluidic system. The cell sample may contain cells of the same type or cells having at least one common characteristic. The liquid cell-containing sample is packed into the microfluidic system. Each microchamber in the microfluidic chamber is equipped with a capture device capable of capturing and binding to a single cell of the cell-containing liquid sample within the microchamber. The properties of the captured cell are then monitored. Based on the monitored properties, a cell may be selected for release. Any selected cell is released by applying an external potential greater than the threshold potential to the capture surface of the capture device in the microchamber containing the selected cell, thereby dissociating the chemical bond between the immobilizer and the capture surface. For the reference potential, the absolute value of the applied potential is greater than the absolute value of the threshold potential. The reference potential may be the reference potential of the liquid sample within the microchamber. The selected and released cells may then be removed / evacuated from the microchamber(s) for further analysis, such as transcriptomic and epigenetic evaluation.
[0065] Therefore, methods for detecting various properties of single cells in cell-containing samples make it possible to correlate measured properties of a single cell, such as metabolism, with the transcriptmic and epigenetic evaluations of that single cell. This correlation may contribute to understanding how properties, such as metabolism, contribute to cellular heterogeneity, potentially providing important guidance for disease treatment.
[0066] The characteristics of the captured cells within each microchamber may be measured optically and / or electrically. Optical monitoring may be performed on the microfluidic system by a microscope or an external light sensor.
[0067] Optionally, optical monitoring is performed on the microfluidic system using a microscope or an external optical sensor.
[0068] Optionally, electrical monitoring is performed by sensors and / or oxygen redox cells.
[0069] Optionally, before monitoring the properties of captured living cells, the microchambers of the microfluidic system can be isolated from each other by closing the first and second openings, such as by filling the first and second channels with a sealing fluid such as oil. In such cases, a further step is taken to remove the sealing fluid before removing the released living cells. Isolating the microchambers can improve electrical measurements in cell-containing liquid samples.
[0070] The embodiments described above accompanying the claims, and / or the examples disclosed above and below in this specification, may be appropriately combined with each other, as will be apparent to those skilled in the art.
[0071] Further features and advantages are disclosed in the following description, claims, and drawings, and will be readily apparent to those skilled in the art from there, or will be understood by practicing this disclosure as described herein.
[0072] Further objectives and advantages of this disclosure, as well as its features, will become apparent from the following description of one or more embodiments with reference to the accompanying drawings. [Brief explanation of the drawing]
[0073] [Figure 1] This figure shows a conceptual top view of a microfluidic apparatus according to an example of the first aspect of the present disclosure. [Figure 2] This figure shows a conceptual top view of a microfluidic apparatus according to an example of the first aspect of the present disclosure. [Figure 3a] This figure shows a conceptual top view of cell arresting using an example. [Figure 3b]This figure shows a conceptual diagram parallel to the flow direction of cell stopping, as illustrated by the example. [Figure 4] This figure shows a conceptual top view of a microfluidic apparatus according to an example of the first aspect of the present disclosure. [Figure 5] This figure shows a conceptual top view of a microfluidic apparatus according to an example of the first aspect of the present disclosure. [Figure 6] This figure shows a conceptual top view of a microfluidic system according to an example of a second aspect of the present disclosure. [Figure 7] This figure shows a conceptual top view of a microfluidic system according to an example of a second aspect of the present disclosure. [Figure 8] This figure shows a conceptual top view of a microfluidic system according to an example of a second aspect of the present disclosure. [Figure 9] This figure shows a flowchart of a method according to an example of a third aspect of the present disclosure. [Figure 10] This figure shows a flowchart of a method according to an example of a third aspect of the present disclosure. [Modes for carrying out the invention]
[0074] This disclosure is described in more detail below with reference to accompanying drawings illustrating examples of embodiments. This disclosure should not be considered limited to the examples of embodiments described. Similar numbers refer to similar elements throughout the description.
[0075] The terminology used herein is for the sole purpose of describing specific aspects of the disclosure and is not intended to limit the invention. Where used herein, the singular forms “a,” “an,” and “the” are also intended to include the plural forms unless the context explicitly indicates otherwise. Unless otherwise specified, all terms used herein (including technical and scientific terms) have the same meaning as they would be commonly understood by those skilled in the art to whom this disclosure belongs.
[0076] Figure 1 shows a microfluidic device 1 for capturing and controllably releasing living cells, the microfluidic device 1 comprising at least one microchamber 10 having a first fluid opening 12 and a second fluid opening 14 for flowing a liquid sample through the microchamber 10.
[0077] The microfluidic apparatus 1 further includes at least one capture device 16 inside the microchamber 10 for capturing at least one living cell 18 inside the microchamber 10. The microfluidic apparatus 1 may also include a substrate 30 extending laterally in a plane A. This plane may have a second axis x and a third axis y perpendicular to the second axis x. Plane A may be perpendicular to a first axis z. The microchamber 10 and the capture device 16 may be placed on the substrate 30. The substrate 30, as well as the axes z, x, y, and plane A, are shown in Figure 1. Please note that although the substrate 30 may also be featured in Figures 2-5, it has been omitted from the drawings for clarity.
[0078] The width W of the microchamber 10 along the third axis y of the microchamber 10 may exceed the entire range of multiple living cells 18 measured along the maximum cell range of the expected maximum living cell size 18 in the cell-containing liquid sample. The width W of the microchamber 10 may allow the living cells 18 to flow with the liquid sample from the first fluid opening 12 to the second fluid opening 14. At least one capture device 16 may be positioned between the first fluid opening 12 and the second fluid opening 14.
[0079] The capture device 16 comprises a conductive capture surface 22 that can be electrically connected to an external potential V via an integrated interconnect. The external potential V may be connected to the capture surface 22 via an integrated electrical interconnect 36 (not shown in Figure 1, but to be described in relation to a second aspect of the present disclosure below). The conductive capture surface 22 may contain a metal or a metallic alloy such as at least 50% silver (Ag) or gold (Au). Silver and gold are excellent conductors and are well suited for forming chemical bonds with immobilizer molecules. The capture device 16 may optionally include a passivation layer on at least a portion of the capture surface 22, the passivation layer being configured to prevent the formation of undesirable junctions on the capture surface 22. The passivation layer may contain thiolated mercaptohexanol (MCH). The passivation layer can prevent contamination of the capture surface 22, such as by preventing unwanted molecules from adhering to the capture surface 22. Contamination could negatively impact the monitoring of the microchamber 10.
[0080] The capture surface 22 is further functionalized by at least one immobilizer selected to bind to at least one living cell 18 within the microchamber 10. The at least one immobilizer is bonded to the capture surface 22 using electrochemically detachable adhesion configured to detach from the capture surface 22 when an external potential V greater than the threshold potential VT is applied to the capture surface 22. For the reference potential, the absolute value of the applied potential V is greater than the absolute value of the threshold potential VT. The reference potential may be the reference potential of the liquid within the microchamber 10.
[0081] Functionalization of the capture surface 22 should be understood as the capture surface being biologically / chemically prepared with selected components, or "immobilizers," configured to bind to living cells 18. The immobilizers are bonded to the capture surface 22 using electrochemically detachable adhesion so as to be released from the capture surface when an external potential V of a predetermined magnitude is applied in relation to a reference potential that exceeds the threshold potential VT. The detachable adhesion is configured to match the absolute value of the threshold voltage in the range of 0.1V to 25 volts, or more preferably in the range of 0.1V to 5V.
[0082] In this specification, "binding" to the living cell 18 within the microchamber 10 should be understood as preventing the living cell 18 from leaving the microchamber 10 through biochemical binding between the cell 18 and the immobilizer of the functionalized capture surface 22.
[0083] The dissociable bond may be a thiol bond, a sulfide bridge, or a sulfur bridge. The immobilizer may include a linker molecule. The linker molecule may be -S-(CH2)x-.
[0084] The immobilizer may include a cell binder selected from nucleotides, amino acids, and / or oligosaccharides, a cell binder selected from DNA, RNA, XNA, and / or antibodies, or a cell binder selected from aptamers and / or antibodies. The immobilizer may also include ligands for affinity binding to living cells 18.
[0085] A substrate containing any of the sensors, electrodes, and cell capture surface 22 within the microfluidic device 1 can be manufactured at low cost in a conventional semiconductor chip casting plant using conventional semiconductor manufacturing techniques. Therefore, the microfluidic device 1 can be mounted on a glass or semiconductor substrate 30 or chip (see Figure 8). Any microstructures of the fluid system on the substrate of this disclosure, such as the walls and top cover of the microchamber 10, and / or any connection channels, may be manufactured by conventional techniques using a single material, for example, polydimethylsiloxane (PDMS) or glass, on a semiconductor or glass substrate 30. The disclosed microfluidic device 1 facilitates direct testing of many captured single cells.
[0086] First and second fluid openings 12 and 14 are positioned to introduce or remove fluid into or from the microchamber. The fluid may be a cell-containing liquid sample, i.e., a liquid sample containing living cells 18, or a fluid containing a culture medium for growing living cells 18. The fluid containing the culture medium may or may not contain antibiotics or other components for performing tests on the living cells 18. The culture medium may also be used to remove the living cells 18 from the microchamber 10.
[0087] The microchamber 1 may be configured to monitor the properties of the captured living cells 18. The microchamber 1 may also be configured for optical monitoring of the captured living cells 18, and the monitored properties may indicate the movement and / or morphology of the captured living cells 18. The microchamber 1 may be placed with an optically transparent cover. Thus, the captured living cells 18 may be optically monitored by a microscope or by an external light sensor (not shown).
[0088] Alternatively, the microchamber 1 may be configured for electrical monitoring of the captured living cells 18, the monitored properties of which may include metabolism, lysis, pyroptosis, and / or apoptosis of the captured living cells. Electrical monitoring may be performed by monitoring the electrically detected properties of the cell-containing solution within the microchamber 1.
[0089] As shown in Figure 2, the capture device 16 may include a cell stopper 24 positioned adjacent to the capture surface 22 and protruding perpendicularly to the capture surface 22. This allows the living cell 18 to be mechanically slowed or even stopped, increasing the opportunity for biochemical conjugation between the living cell 18 and the capture surface 22.
[0090] Figures 3a and 3b illustrate how the cell stopper 24 may be configured such that its width w and height h are greater than the maximum cell range of the living cells 18 intended to be captured using the microfluidic device 1. The width w and height h are the extent of the protruding cell stopper 24 perpendicular to the direction of fluid flow through the operating microchamber 10. The width w may extend substantially parallel to a third axis y. The height h may extend substantially parallel to a first axis z. The microfluidic device may further be configured to align with fluid flow substantially along a second axis x.
[0091] A sufficiently large cell stopper 24 increases the chance of holding and slowing a single living cell 18. The cell stopper 24 is configured such that its width w and / or height h are less than three times the maximum cellular range of the living cell 18 intended to be captured using the microfluidic device 1. By making the cell stopper 24 even larger, the chance of capturing a living cell 18 can be increased.
[0092] The cell stopper 24 has a concave surface 25 that, when viewed from the first fluid opening 12, faces the first fluid opening 12 and is adjacent to the capture surface 22, but positioned on the opposite side of the capture surface 22. Thus, living cells packed into the microchamber 10 can flow over the capture surface 22 and be stopped or slowed by the cell stopper 24 on the opposite side of the capture surface 22. The concave surface 25 can increase the opportunity for the cell stopper 24 to hold the living cells 18 until a biochemical junction is formed between the living cells 18 and the immobilizer.
[0093] The cell trap 24 may include a microchannel 27 positioned to penetrate the cell trap 24. The microchannel may extend along the total height h of the cell trap 24, but may be considerably narrower than the width w of the cell trap to prevent living cells 18 from entering the microchannel 27. The microchannel has a first aperture 27' on the concave surface 25 and a second aperture 27'' on another surface of the cell trap 24, the second aperture 27'' being closer to the second fluid opening 14 compared to the first aperture 27'. A portion of the fluid (liquid sample) can flow into the void formed by the concave surface 25 and pass through the microchannel 27 toward the second fluid opening 14 of the microchamber 10, so that the fluid flow helps to draw living cells 18 into the void formed by the concave surface 25, thereby improving the trapping properties of the cell trap 24.
[0094] Various types of living cells 18 can vary in size from several hundred nanometers to several tens of micrometers. The disclosed microfluidic apparatus 1 and microfluidic system 2 can be manufactured and housed by the laboratory in various sizes intended for a wide range of living cell diameters. Thus, to test a given living cell type, the size of the living cell type may be determined, and a correspondingly sized test system having a microchamber 10 sized for an appropriate range of living cell sizes may be selected from the housed test systems. In particular, the maximum and / or minimum cell range of a given living cell type is determined.
[0095] Alternatively, if the type of living cell is unknown, a test system may be selected that includes differently sized microchambers 10, each sized to accommodate a different predetermined range of cell sizes. As a result, time is saved because the living cells 18 do not need to be examined before the test / monitoring begins.
[0096] In this specification, a predetermined range of cell sizes should be understood as a limited range of biological cells / sizes, i.e., a range of cell sizes that allows for the dissociation / detection of similarly sized but not necessarily identically sized cells. Thus, a particular microchamber 10 will be designed to accommodate a limited range of cell sizes for testing. Other microfluidic devices 1 may be simultaneously designed and used in the microfluidic system 2 for other predetermined ranges of biological cell sizes, thereby enabling blind testing of unknown types and sizes of cells. This is because, in the microfluidic system 2 of the microchambers, some of the microchambers 10 will be correctly sized for unknown cell types.
[0097] As illustrated in Figure 4, the microchamber 1 may include an integrated sensor 20. The sensor may be configured to monitor the characteristics of captured living cells 18. The sensor 20 may be an integrated semiconductor electronic sensor 20 for monitoring the activity state of cells in real time. "Integrated" means that the sensor 20 can be manufactured on a substrate by conventional semiconductor processing techniques. The measured characteristics may indicate the metabolism, lysis, pyroptosis, and / or apoptosis of the captured living cells 18.
[0098] The integrated sensor 20 may be an ion-sensitive field-effect transistor (ISFET), such as a potentiometric ion sensor, and the ion-sensitive field-effect transistor may be configured to monitor the metabolism of living cells by monitoring the pH change induced by the metabolism of a cell-containing liquid sample.
[0099] From a detection standpoint, measuring the potential difference of pH using a field-effect transistor is more reliable than directly measuring the resistance (or impedance) of a cell-containing liquid sample. This is because contributions from the solid-liquid interface between the electrode and the liquid can introduce large and irregular errors into resistance measurements.
[0100] Furthermore, direct monitoring of physiological parameters (such as the pH of a liquid) can potentially be faster than optical monitoring of cell growth because it does not rely on visible morphological changes synchronized with signal generation. Monitoring of physiological parameters can potentially provide a real-time overview of the drug response of living cells 18 using highly sensitive and reliable field-effect transistor-based ion sensors 20. The effect of the drug can be immediately detected from changes in electrical signals generated by monitored characteristics such as cellular metabolism. The tests are all electrical and can be obtained based on current-voltage measurements using conventional instruments.
[0101] Before monitoring the cell-containing sample in the microchamber 10, the first fluid opening 12 and / or the second fluid opening 14 may be closed with a sealing fluid such as oil, or by valves that allow fluid communication between the fluid openings 12 and 14.
[0102] The capture device 16 may be configured to capture a single living cell 18 within the microchamber. The capture device 16 may be sized, for example, to accommodate only a single living cell 18. This would prevent any further cells 18 within the microchamber 10 from being bound by the capture device 16 and would be repelled from the microchamber by the fluid flow through the second fluid opening 14 before monitoring begins.
[0103] The first fluid opening 12 and the second fluid opening 14 may be located on either side of the capture device 16 in the lateral direction. This allows the capture device 16 to be positioned in the flow of the liquid sample.
[0104] During monitoring, if a predetermined characteristic of a living cell 18 is detected within the microchamber 10, the cell possessing that characteristic may be selected for further investigation and released from the microchamber 10, evacuated / removed. The released cell(s) 18 possessing that characteristic may be sent out for further evaluation along with any other cells identified by that characteristic within a microfluidic system 2 (which will be described in more detail below) comprising multiple such microfluidic devices 1.
[0105] As a result, this disclosure enables the analysis and better understanding of cellular heterogeneity, particularly metabolic heterogeneity, in cell populations. In other words, after exposing a sample of cells to a test component such as a predetermined antibiotic, one or more cells exhibiting various properties, such as resistance to the antibiotic, may be selected for further testing (such as transcriptomic and epigenetic evaluations). Measured properties of a single cell, such as metabolism, may be correlated with transcriptomic and epigenetic evaluations of the same single cell, and this correlation may contribute to an understanding of how properties such as metabolism contribute to cellular heterogeneity, potentially providing important guidance for the treatment of diseases.
[0106] The sensor 20 may be an integrated semiconductor electronic sensor 20 for monitoring the activity state of cells in real time. "Integrated" means that the sensor 20 can be manufactured on a substrate using conventional semiconductor processing techniques. The measured characteristics may indicate the metabolism, lysis, pyroptosis, and / or apoptosis of the captured living cells 18.
[0107] The integrated sensor 20 may be an ion-sensitive field-effect transistor (ISFET), such as a potentiometric ion sensor, and the ion-sensitive field-effect transistor may be configured to monitor the metabolism of living cells by monitoring the pH change induced by the metabolism of a cell-containing liquid sample.
[0108] From a detection standpoint, measuring the potential difference of pH using a field-effect transistor is more reliable than directly measuring the resistance (or impedance) of a cell-containing liquid sample. This is because contributions from the solid-liquid interface between the electrode and the liquid can introduce large and irregular errors into resistance measurements.
[0109] Furthermore, direct monitoring of physiological parameters (such as the pH of a liquid) can potentially be faster than optical monitoring of cell growth because it does not rely on visible morphological changes synchronized with signal generation. Monitoring of physiological parameters can potentially provide a real-time overview of the drug response of living cells 18 using highly sensitive and reliable field-effect transistor-based ion sensors 20. The effect of the drug can be immediately detected from changes in electrical signals generated by monitored characteristics such as cellular metabolism. The tests are all electrical and can be obtained based on current-voltage measurements using conventional instruments.
[0110] As shown in Figure 5, the microfluidic apparatus 1 may further include a first electrode 26 configured to define a reference potential of the liquid in the microchamber. If the microchamber includes an integrated sensor, the first electrode can define a reference potential for the integrated sensor, e.g., a reference liquid potential. Similar to the capture surface 22, the first electrode 26 may be electrically connected to an external measuring unit via an integrated electrical interconnect 36 (not shown in Figure 5). The first electrode may be made of a material selected from silver chloride (AgCl) or silver (Ag) to at least 50%.
[0111] Furthermore, the microchamber 10 may include a second electrode 28. The second electrode 28 may be made of at least 50% platinum (Pt). The first electrode 26 and the second electrode 28 can form an oxygen redox cell 40 for measuring the oxygen content and / or oxygen concentration within the microchamber (10). The first electrode 26, the second electrode 28, and the resulting oxygen redox cell 40 may be electrically connected to an external measuring unit via an integrated electrical interconnect 36 (not shown in Figure 5). Thus, the microchamber 1, further comprising the sensor 20, may be configured to monitor any one of the following: oxygen content, oxygen concentration, and acidification / metabolism, or a combination thereof.
[0112] Figures 6 and 7 illustrate an example of a second aspect of the present disclosure. A microfluidic system 2 comprising multiple microfluidic devices 1 according to any one of the examples of the first aspect of the present disclosure is shown. Although a microfluidic system 2 comprising microfluidic devices 1 according to Figure 1 is depicted in Figure 6, and a microfluidic system 2 comprising microfluidic devices 1 according to Figure 2 is depicted in Figure 7, it should be understood that any exemplary microfluidic device 1 from any of the first aspects of the present disclosure, such as Figure 4 and / or Figure 5, may be included in the microfluidic system 2. Each microchamber 10 is fluidly connected to a first fluid channel 32 via a first fluid opening 12 and to a second fluid channel 34 via a second fluid opening 14.
[0113] The arrows illustrate how a fluid, such as a cell-containing liquid sample, can flow through the microfluidic system 2, passing through the first fluid opening 12 to the first fluid channel 32, into the microchamber 10, through the microchamber 10, through the second fluid opening 14, and into the second fluid channel 34, in order to deliver selected cells out of the microchamber. As will be discussed below, the fluid flow may be reversed depending on the circumstances, as shown in Figure 7.
[0114] Figures 6 and 7 further illustrate the released living cells 18'. Simultaneously with the identification of living cells 18 having predetermined characteristics, an external potential V, which may be positive or negative in relation to a reference potential, can be applied to each capture surface 22 via an integrated electrical interconnect 36 to dissociate the electrochemical junction between the immobilizer and the capture surface 22. In the example of Figures 6 and 7, the intermediate microchamber 10 is shown to contain the released cells 18'. Compared to the living cells 18 in the two other microchambers 10, the released cells 18' are shown to be drifting, with the fluid flowing away from the capture surface 22 towards the fluid channels 32 or 34. As shown, the reverse flow depicted in Figure 7 is particularly advantageous for removing cells from the cell stoppers 24 when the microchamber 10 is equipped with cell stoppers 24.
[0115] As shown in Figure 8, the microfluidic system 2 may comprise at least one array 42 of microfluidic devices 1 interconnected by first and second fluid channels 32, 34. Figures 6 and 7 show three microfluidic devices 1 in array 42. However, any number of microfluidic devices 1 may be included in array 42. Array 42 is defined such that the collections of microfluidic devices 1 are interconnected by the same first channel 32 and the same second channel 34. The microfluidic system 2 may further comprise multiple arrays 42 of microfluidic devices 1, each array 42 of microfluidic devices 1 interconnected by their respective first channel 32 and second channel 34. Each array 42 of microfluidic devices may be supplied with a liquid cell-containing sample from an external source during testing. The first fluid openings 12 and second fluid openings 14 of the microfluidic devices 1 included in the microfluidic system 2 may be closed by the first fluid channels 32 and / or the second fluid channels 34. The first fluid opening 12 and / or the second fluid opening 14 may be closed by filling the first fluid channel 32 and / or the second fluid channel 34 with a sealing fluid such as oil. Alternatively, the first fluid opening 12 and / or the second fluid opening 14 may be closed by closing valves (not shown) to which the first fluid channel 32 and the second fluid channel 34 are connected. By closing the microfluidic device 1 and thereby isolating the microchambers 10 from each other, the quality of electrical monitoring of the characteristics of living cells in each microchamber 10 can be improved.
[0116] The microfluidic system 2 may further include an integrated electrical interconnect 36 configured to electrically connect any of the electrodes and sensors in the microfluidic device 1 to an external electrical unit for monitoring an external potential V and selectively applying the external potential V to the capture surface 22 of the capture device 16, in order to selectively disengage the immobilizer from the capture surface 22 of the capture device 16.
[0117] The microfluidic system 2 may further include a control unit 38 electrically connected to the microfluidic system 2 via an integrated electrical interconnect 36 for monitoring the activity of living cells in at least one microfluidic device 1. The control unit 38 may also be electrically connected to a sensor 20 of at least one microchamber 10 and may be configured to apply an external potential V to at least one capture surface 22 of the capture device 16 to selectively dissociate the immobilizer from the capture surface 22 based on the measured characteristics of the captured living cell 18.
[0118] The control unit 38 may be electrically connected to the microfluidic system 2 via an integrated electrical interconnect 36 to receive signals from each of the sensors 20 in the microchamber 10 included in the microfluidic system 2. The control unit 38 may optionally be further connected to a first electrode 26 and a second electrode 28 (Figure 5), thereby connecting to an oxygen redox cell 40. The control unit 38 can interpret the measurements from the sensors and / or the oxygen redox cell 40 to provide a rapid presentation of the response of living cells 18 in the microchamber 10. After displaying the results of the measured characteristics to the operator, the control unit 38 can automatically or manually apply a potential V to a selected capture surface based on the measured characteristics.
[0119] Figure 9 illustrates a third aspect of the present disclosure, showing Method 3 for testing living cells 18 using a microfluidic system 2 according to one of the examples of the second aspect of the present disclosure. Method 3 is, - Step S1 involves flowing a cell-containing liquid sample through a microchamber 10 in a first direction to pack at least one living cell 18 into at least one microfluidic device 1. - Step S2 involves capturing living cells 18 with the capture device 16, - Step S3 involves monitoring the characteristics of the captured living cells 18, - Step S4 involves selecting captured living cells 18 for release based on the monitored characteristics. - Step S5 involves applying an external potential V greater than the threshold potential VT to the capture surface 22 of the capture device 16, thereby capturing the selected living cells 18 by the capture device 16, thereby releasing the chemical bonds, and thus releasing the selected living cells 18. -The procedure includes step S6 of removing the released living cells 18 from the microfluidic device 1 by flowing a fluid through the microchamber 10 in a first direction or a second direction opposite to the first direction.
[0120] Thus, a cell-containing liquid sample is prepared and fluidly connected to at least one microfluidic device 1 of the microfluidic system 2 via a first fluid channel 32 and / or a second fluid channel 34. The cell sample may contain living cells 18 of the same type, or living cells 18 having at least one common characteristic. The liquid cell-containing sample is packed into the microfluidic system 2. Each microchamber 10 of the microfluidic device 1 of the microfluidic system 2 is equipped with a capture device 16 that can capture a single living cell 18 of the cell-containing liquid sample within the microchamber 10 and bind to that single cell.
[0121] The characteristics of the captured cells in each microchamber may be measured optically and / or electrically. Optical monitoring may be performed by an external light sensor relative to a microscope or microfluidic system 2. Electrical monitoring may be performed by a sensor 20 and / or oxygen redox cell 40 integrated with and contained within the microchamber 1.
[0122] Based on the measured characteristics, cells may be selected for release. Any selected living cell 18 is released by applying an external potential V greater than the threshold potential VT to the capture surface 22 of the capture device 16 in the microchamber 10 containing the selected living cell 18, thereby dissociating the chemical bond between the immobilizer and the capture surface 22. For the reference potential, the absolute value of the applied potential V is greater than the absolute value of the threshold potential VT. The reference potential may be the reference potential of the liquid sample in the microchamber. The selected and released living cell 18 may then be removed / evacuated from the microchamber(s) 10 for further analysis as illustrated and described above in relation to Figures 6 and 7.
[0123] As shown in Figure 10, prior to monitoring the properties of the captured living cells 18 in S3, the microchambers 10 of the microfluidic system 2 can be isolated from each other by closing the first and second openings 12 and 14 in S7, for example, by filling the first and second channels 32 and 34 with a sealing fluid such as oil. In such cases, a further step S8 is performed to remove the sealing fluid before applying an external potential in S5 to dissociate the adhesion and release the living cells 18. By isolating the microchambers 10, the accuracy of electrical measurements in the cell-containing liquid sample can be improved. Thus, since Method 3 can detect various properties of a single living cell 18 in a cell-containing sample, it becomes possible to correlate the measured properties of a single living cell 18, such as metabolism, with the transcriptmic and epigenetic evaluation of the same single cell. This correlation may contribute to an understanding of how properties such as metabolism contribute to cellular heterogeneity, which may provide important guidance for the treatment of diseases.
[0124] The first direction is defined by the flow of fluid through the microchamber 10, via the first opening 12 and the second opening 14, from the first fluid channel 32 to the second fluid channel 34, as indicated by the arrows in the microchamber 1 of Figure 6.
[0125] The second direction of fluid flow is defined by the fluid flowing through the microchamber 10 through the second opening 14 and the first opening 12, from the second fluid channel 34 to the first fluid channel 32, as indicated by the arrows in the microchamber 1 of Figure 7. Thus, the second direction of fluid flow for extracting S6 from the microfluidic device 1 is in the opposite direction to the fluid flow for packing S1 into the microfluidic device 1. The reverse direction of extraction S6 may be particularly advantageous for removing living cells 18 from the cell stopper 24 when the capture device 16 is equipped with a cell stopper 24, as shown in Figure 7.
Claims
1. A microfluidic device (1) for capturing a single living cell (18) and controlling the release of a selected single living cell (18), - A microchamber (10) having a first fluid opening (12) and a second fluid opening (14) for flowing a liquid sample through the microchamber (10), - comprising at least one capture device (16) inside the microchamber (10) for capturing at least one living cell (18) inside the microchamber (10), Microfluidic device (1), comprising a capture device (16) having a conductive capture surface (22) electrically connectable to an external potential (V), the capture surface (22) being further functionalized by at least one immobilizer selected to bind to at least one living cell (18) in the microchamber (10), the at least one immobilizer being bonded to the capture surface (22) using electrochemically detachable adhesion configured to detach from the capture surface (22) when an external potential (V) greater than a threshold potential (VT) is applied to the capture surface (22).
2. The microfluidic apparatus (1) according to claim 1, wherein the detachable adhesion is configured to match the absolute value of the threshold potential (VT) in the range of 0.1V to 25V, or more preferably in the range of 0.1V to 5V.
3. The microfluidic apparatus (1) according to claim 1 or 2, wherein the capture device (16) is configured to capture a single living cell (18) in the microchamber (10).
4. The microfluidic apparatus (1) according to any one of claims 1 to 3, wherein the capture device (16) comprises a cell stopper (24) positioned adjacent to the capture surface (22) and protruding perpendicularly to the capture surface (22).
5. The microfluidic device (1) according to claim 4, wherein the cell stopper (24) is configured to have a width (w) and height (h) greater than the maximum cellular range of the living cells (18) intended to be captured using the microfluidic device (1), the width (w) and height (h) being the range of the protruding cell stopper (24) perpendicular to the direction of fluid flow through the operating microchamber (10).
6. The microfluidic device (1) according to claim 5, wherein the cell stopper (24) is configured such that the width (w) and / or height (h) is less than three times the maximum cellular range of the living cells (18) that are intended to be captured using the microfluidic device (1).
7. The microfluidic apparatus (1) according to any one of claims 4 to 6, wherein the cell stopper (24) comprises a concave surface (25) that, when viewed from the first fluid opening (12), faces the first fluid opening (12), is adjacent to the capture surface (22) and is located on the opposite side of the capture surface (22).
8. The microfluidic device (1) according to claim 7, wherein the cell stopper (24) comprises a microchannel (27) positioned to penetrate the cell stopper (24), the microchannel (27) having a first aperture (27') on the concave surface (25) and a second aperture (27'') on another surface of the cell stopper (24), the second aperture (27'') being closer to the second fluid (14) opening compared to the first aperture (27').
9. The microfluidic apparatus (1) according to any one of claims 1 to 8, wherein the conductive trapping surface (22) includes a metal or a metal alloy.
10. The microfluidic apparatus (1) according to any one of claims 1 to 9, wherein the conductive trapping surface (22) contains at least 50% Ag or Au.
11. The microfluidic apparatus (1) according to any one of claims 1 to 10, wherein the electrochemically dissociable adhesion between the capture surface (22) and the at least one immobilizer is a thiol bond, a sulfide bridge, or a sulfur bridge.
12. The microfluidic device (1) according to any one of claims 1 to 11, wherein the immobilizer includes a linker molecule.
13. The microfluidic apparatus (1) according to claim 12, wherein the linker molecule is -S-(CH2)x-.
14. The microfluidic apparatus (1) according to any one of claims 1 to 13, wherein the capture device (16) comprises a passivation layer on at least a portion of the capture surface (22), the passivation layer being configured to prevent the formation of undesirable bonding on the capture surface (22).
15. The microfluidic apparatus (1) according to claim 14, wherein the passivation layer contains thiolated mercaptohexanol (MCH).
16. The microfluidic device (1) according to any one of claims 1 to 15, wherein the immobilizer comprises a cell binder selected from nucleotides, proteins, and / or oligosaccharides.
17. The microfluidic device (1) according to any one of claims 1 to 16, wherein the immobilizer comprises a cell binder selected from DNA, RNA, XNA, and / or an antibody.
18. The microfluidic device (1) according to any one of claims 1 to 17, wherein the immobilizer comprises a cell binder selected from aptamers and / or antibodies.
19. The microfluidic device (1) according to any one of claims 1 to 18, wherein the immobilizer includes a ligand for affinity binding with the living cell (18).
20. The microfluidic apparatus (1) according to any one of claims 1 to 19, wherein the microchamber (10) is configured to monitor the characteristics of the captured living cells (18).
21. The microfluidic apparatus (1) according to claim 20, wherein the microchamber (10) is configured for optical monitoring of the captured living cells (18), and the monitored characteristics indicate the movement and / or morphology of the captured living cells (18).
22. The microfluidic device (1) according to claim 20 or 21, wherein the microchamber (10) is configured for electrical monitoring of the captured living cells (18), and the monitored characteristics indicate metabolism, lysis, pyroptosis, and / or apoptosis of the captured living cells (18).
23. The microfluidic apparatus (1) according to claim 22, wherein the microchamber (10) comprises an integrated sensor (20), the sensor (20) is configured to monitor the characteristics of the captured living cells (18).
24. The microfluidic apparatus (1) according to claim 23, wherein the integrated sensor (20) is an ion-sensitive field-effect transistor (ISFET).
25. The microfluidic apparatus (1) according to any one of claims 1 to 24, wherein the microchamber (10) comprises a first electrode (26) configured to define the reference potential of a liquid sample flowing through the microchamber (10).
26. The microfluidic apparatus (1) according to claim 25, wherein the first electrode (26) is made of a material selected from silver chloride (AgCl) or silver (Ag) to at least 50%.
27. The microfluidic apparatus (1) according to claim 25 or 26, wherein the microchamber (10) comprises a second electrode (28).
28. The microfluidic apparatus (1) according to claim 28, wherein the second electrode (28) is made of at least 50% platinum (Pt).
29. The microfluidic apparatus (1) according to claim 27 or 28, wherein the first electrode (26) and the second electrode (28) form an oxygen redox cell (40) for measuring the oxygen content and / or oxygen concentration in the microchamber (10).
30. The microfluidic apparatus (1) according to any one of claims 1 to 29, comprising a substrate (30) extending laterally in a plane (A), the microchamber (10) and the capture device (16) being arranged on the substrate (30).
31. A microfluidic system (2) comprising a plurality of microfluidic devices (1) according to any one of claims 1 to 30, wherein each microchamber (10) is fluidly connected to a first fluid channel (32) via a first fluid opening (12) and to a second fluid channel (34) via a second fluid opening (14).
32. The microfluidic system (2) according to claim 31, further comprising an integrated electrical interconnect (36) configured to electrically connect any electrode and sensor in the microfluidic device to an external electrical unit for monitoring an external potential V and selectively applying the external potential V to the capture surface (22) of the capture device (16) in order to selectively disengage the immobilizer from the capture surface (22) of the capture device (16).
33. - Step (S1) of packing at least one living cell (18) into at least one microfluidic device (1) by flowing a cell-containing liquid sample through a microchamber (10) in a first direction, - A step (S2) of capturing living cells (18) with a capture device (16), - A step (S3) to monitor the characteristics of the captured living cells (18), - A step (S4) of selecting captured living cells (18) for release based on monitored characteristics, - Step (S5) of applying an external potential V greater than the threshold potential to the capture surface (22) of the capture device (16) in which the selected living cell (18) is captured, thereby dissociating the chemical bond and thereby releasing the selected living cell (18), A method (3) for capturing and releasing living cells (18) using a microfluidic system (2) according to any one of claims 30 to 32, comprising the step (S6) of removing the released living cells (18) from the microfluidic device (1) by flowing a fluid through the microchamber (10) in a first direction or a second direction opposite to the first direction.
34. The method according to claim 33 (3), wherein the step (S3) of monitoring the characteristics of the captured living cells (18) is performed by optical monitoring and / or electrical monitoring.
35. The method according to claim 34 (3), wherein optical monitoring is performed by a microscope or by an external light sensor on the microfluidic system 2.
36. The method according to claim 34 (3), wherein electrical monitoring is performed by a sensor (20) and / or an oxygen redox cell (40).
